insulin vs glp-1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1 Drugs and Type 1

If you don't have a BMI over 35 but have A BMI over 30 and either have heart failure with preserved ejection fraction, chronic kidney disease stage three A or above, uncontrolled high blood pressure on two or more anti-hypertensive agents, then you qualify

This is why instructions for injectable peptide medications typically specify gentle handling - you should never vigorously shake a vial of compounded GLP-1 medication

Studies have evaluated glutathione for antioxidant defense.*

When used alone or in combination with selenium, 30 mg of zinc per day may help enhance thyroid function in people with Hashimotos disease (20Trusted Source, 21Trusted Source)

Table 1 Human studies of TMAO as a potential novel and independent risk factor for predicting clinical risk of atherosclerosis (AS) and prognostic stratification